These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7087954)

  • 41. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of myasthenia gravis by preventing acetylcholine receptor modulation.
    Losen M; Martínez-Martínez P; Phernambucq M; Schuurman J; Parren PW; De Baets MH
    Ann N Y Acad Sci; 2008; 1132():174-9. PubMed ID: 18567867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies.
    Lee SW; Sullenger BA
    Nat Biotechnol; 1997 Jan; 15(1):41-5. PubMed ID: 9035104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
    Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
    J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of human antibody and murine monoclonal antibody with muscle acetylcholine receptor.
    Dwyer DS; Kearney JF; Bradley RJ; Kemp GE; Oh SJ
    Ann N Y Acad Sci; 1981; 377():143-57. PubMed ID: 6951469
    [No Abstract]   [Full Text] [Related]  

  • 46. Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: receptor loss in cell culture.
    Sideris S; Lagoumintzis G; Kordas G; Kostelidou K; Sotiriadis A; Poulas K; Tzartos SJ
    J Neuroimmunol; 2007 Sep; 189(1-2):111-7. PubMed ID: 17617475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anesthetic considerations for thymectomy in a patient having an anti-acetylcholine receptor antibody without myasthenia gravis].
    Koshida T; Hara K; Obara G; Sata T
    Masui; 2008 Aug; 57(8):993-5. PubMed ID: 18710007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic and antibody-mediated channelopathies at the neuromuscular junction.
    Vincent A; Mills K
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():250-8. PubMed ID: 10689470
    [No Abstract]   [Full Text] [Related]  

  • 49. [Plasma exchange in myasthenia gravis].
    Redeker M; Meyer-Wahl L
    Nervenarzt; 1982 Dec; 53(12):729-32. PubMed ID: 7155236
    [No Abstract]   [Full Text] [Related]  

  • 50. Myasthenia gravis: an example of receptor disease.
    Conti-Tronconi BM; Fumagalli G; Scotti A; Brigonzi A; Sher E; Morgutti M; Clementi F
    Adv Biochem Psychopharmacol; 1980; 21():473-88. PubMed ID: 7376974
    [No Abstract]   [Full Text] [Related]  

  • 51. Lipoprotein-like receptor 4 antibodies in myasthenia gravis: pathogenic or protective.
    Richman DP
    Eur J Neurol; 2016 Nov; 23(11):1593-1594. PubMed ID: 27753233
    [No Abstract]   [Full Text] [Related]  

  • 52. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
    Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
    Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental autoimmune myasthenia gravis.
    De Baets MH; Verschuuren J; van Breda Vriesman PJ
    Monogr Allergy; 1988; 25():1-11. PubMed ID: 3050455
    [No Abstract]   [Full Text] [Related]  

  • 55. Bread-and-butter in diagnosis of myasthenia gravis.
    Chan AY; Liu DT
    Arch Neurol; 2005 Dec; 62(12):1939; author reply 1939-40. PubMed ID: 16344357
    [No Abstract]   [Full Text] [Related]  

  • 56. 'Seronegative' myasthenia gravis is no longer seronegative.
    Lindstrom J
    Brain; 2008 Jul; 131(Pt 7):1684-5. PubMed ID: 18558616
    [No Abstract]   [Full Text] [Related]  

  • 57. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoantibodies to receptors by an autoantiidiotypic route.
    Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Sarangarajan R; Penn AS
    Ann N Y Acad Sci; 1987; 505():416-22. PubMed ID: 3500668
    [No Abstract]   [Full Text] [Related]  

  • 59. Monoclonal and anti-idiotypic antibodies as probes for receptor structure and function.
    Venter JC; Berzofsky JA; Lindstrom J; Jacobs S; Fraser CM; Kohn LD; Schneider WJ; Greene GL; Strosberg AD; Erlanger BF
    Fed Proc; 1984 Jul; 43(10):2532-9. PubMed ID: 6203777
    [No Abstract]   [Full Text] [Related]  

  • 60. Antiidiotypic antibodies as probes for receptor structure and function.
    Farid NR; Lo TC
    Endocr Rev; 1985; 6(1):1-23. PubMed ID: 2579804
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.